HIV and the Seroprevalence of SARS-CoV-2

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study was self-funded by Clinical Reference Laboratory, Lenexa, KS 66215

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All participants signed disclosures indicating that results may be used for research purposes. Western IRB (Puyallup, WA) reviewed the study under the Common Rule and applicable guidance and determined it is exempt under 45 CFR 46.104(d)(4) using de-identified study samples for epidemiologic investigation. WIRB Work Order #1-1324846-1.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes